Timothy Lymberiou

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial

Douglas Brand, Alison Tree, Peter Ostler et al. · The Lancet Oncology · 2019 · 519 citations · Full text

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial

Alison Tree, Peter Ostler, H. van der Voet et al. · The Lancet Oncology · 2022 · 280 citations · Full text

Predictors of breast radiotherapy plan modifications: Quality assurance rounds in a large cancer centre

Timothy Lymberiou, Susanne Galuszka, Grace Lee et al. · Radiotherapy and Oncology · 2014 · 24 citations

Adaptive Radiotherapy, Large Cancer Centre, Quality Assurance +10

Omission of Breast Radiotherapy in Low-risk Luminal A Breast Cancer: Impact on Health Care Costs

Kathy Han, Mei Ling Yap, J.H.E. Yong et al. · Clinical Oncology · 2016 · 11 citations · Full text

Surgical Oncology, Breast Oncology, Radiation Therapy +10